---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-019210"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2024-03-04T23:59:59+00:00"
generated_at: "2026-06-05T04:47:31.189077+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bluejay Diagnostics receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Closing bid price below $1.00 for 30 consecutive business days; non-compliance with Nasdaq Listing Rule 5550(a)(2).
- Company has 180 days, until August 26, 2024, to regain compliance by closing at $1.00+ for ten consecutive days.
- If not cured, Company may be eligible for additional 180-day period, but delisting risk exists if unable to comply.
- Company intends to take reasonable measures to regain compliance but no assurance of success.

## SEC filing metadata
- accession: 0001213900-24-019210
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2024-03-04T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390024019210/0001213900-24-019210-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390024019210/ea0201073-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-019210
- JSON: https://secwatch.observer/filing/0001213900-24-019210.json
- Plain text: https://secwatch.observer/filing/0001213900-24-019210.txt

## Key facts
- Listing & Compliance Notices
  Bluejay Diagnostics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: February 28, 2024, Bluejay Diagnostics, Inc. (the “Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that the closing bid price for its common stock had been below $1.00 for the previous 30 consecutive business days and that the Company therefore is not in compliance with the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The notification has no immediate effect on the listing of the Company’s common stock on The Nasdaq Capital
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390024019210/0001213900-24-019210-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.